Recommendations for detection of individual risk for comorbidities in patients with psoriasis

Archives of Dermatological Research

Volumn 305, Issue 2, 2013, Pages 91-98

  Wohlrab, Johannes ^a   Fiedler, Gabriele ^b   Gerdes, Sascha ^c   Nast, Alexander ^d   Philipp, Sandra ^d   Radtke, Marc A ^e   Thaçi, Diamant ^f   Koenig, Wolfgang ^g   Pfeiffer, Andreas F H ^d   Härter, Martin ^e   Schön, Michael P ^h  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Dermatological Practice ^*  (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g UNIVERSITY OF ULM   (Germany)

^h UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Comorbidities; Psoriasis

Indexed keywords

C REACTIVE PROTEIN;

AGING; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHECKLIST; CHRONIC DISEASE; COMORBIDITY; DISEASE SEVERITY; DYSLIPIDEMIA; HOMOCYSTINURIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MENTAL DISEASE; MENTAL STRESS; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; STANDARD; TOBACCO DEPENDENCE;

AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; CHECKLIST; COMORBIDITY; GERMANY; HUMANS; METABOLIC SYNDROME X; PRACTICE GUIDELINES AS TOPIC; PSORIASIS; RISK; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES;

EID: 84878871883     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1318-9     Document Type: Review

References (60)

1. Abou-Raya A, Abou-Raya S (2006) Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5:331-337
2. Abraham JM, Cho L (2010) The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med 77:911-918
3. Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM (2010) Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK. Br J Dermatol 163:586-592
4. Ahlehoff O (2011) Psoriasis and cardiovascular disease: epidemiological studies. Dan Med Bull 58:B4347
5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
6. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
7. Alsufyani MA, Golant AK, Lebwohl M (2010) Psoriasis and the metabolic syndrome. Dermatol Ther 23:137-143
8. Angeli V, Llodra J, Rong JX, Satoh K, Ishii S, Shimizu T, Fisher EA, Randolph GJ (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21:561-574
9. Ascaso JF, Millan J, Mateo-Gallego R, Ruiz A, Suarez-Tembra M, Borrallo RM, Zambon D, Gonzalez-Santos P, Peres-de-Juan M, Ros E (2011) Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population. Eur J Intern Med 22:177-181
10. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I (2010) Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 162:633-636
11. Benesch L, Bjarnason-Wehrens B, Cordes C, Franz I-W, Grunze M, Gysan D, Hoberg E, Hoffmann K, Klein G, Miche E, Schröder K, Theisen F, Tönnesmann U, Völler H, Volger E, Willemsen D, Wirth A, Witt T (2003) Umsetzungsempfehlung der Leitlinie arterielle Hypertonie für die kardiologische Rehabilitation. Herzmedizin 20:209-222
12. Brazzelli V, Grasso V, Fornara L, Moggio E, Gamba G, Villani S, Borroni G (2010) Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity. Int J Immunopathol Pharmacol 23:911-916
13. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project. Alcohol Use Disorders Identification Test. Arch Intern Med 158:1789-1795
14. Cakmak SK, Gul U, Kilic C, Gonul M, Soylu S, Kilic A (2009) Homocysteine, vitamin B12 and folic acid levels in psoriasis patients. J Eur Acad Dermatol Venereol 23:300-303
15. Church T (2011) Exercise in obesity, metabolic syndrome, and diabetes. Prog Cardiovasc Dis 53:412-418
16. Cohen AD, Weitzman D, Dreiher J (2010) Psoriasis and hypertension: a case-control study. Acta Derm Venereol 90:23-26
17. Dauden E, Castaneda S, Suarez C, Garcia-Campayo J, Blasco AJ, Aguilar MD, Ferrandiz C, Puig L, Sanchez-Carazo JL (2012) Integrated approach to comorbidity in patients with psoriasis. Actas Dermosifiliogr 103(Suppl 1):1-64
18. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
19. Favato G (2008) High incidence of smoking habit in psoriatic patients. Am J Med 121:e17
20. Francis K (1998) The burden of physical inactivity & cardiovascular heart disease. Compr Ther 24:87-92
21. Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, Grundy SM, Jarratt MT, Krueger JG, Ridker PM, Stone N, Roberts WC (2008) AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 102:1631-1643
22. Fortes C, Mastroeni S, Leffondre K, Sampogna F, Melchi F, Mazzotti E, Pasquini P, Abeni D (2005) Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 141:1580-1584
23. Gerdes S, Zahl VA, Weichenthal M, Mrowietz U (2010) Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology 220:38-43
24. Gisondi P, Farina S, Giordano MV, Girolomoni G (2010) Usefulness of the framingham risk score in patients with chronic psoriasis. Am J Cardiol 106:1754-1757
25. Goldstein LB, Whitsel LP, Meltzer N, Schoeberl M, Birnbaum J, Nelson S, Gardner TJ, Yancy CW, Gibbons RJ, Sacco RL, Hiratzka L (2011) American Heart Association and nonprofit advocacy: past, present, and future. A policy recommendation from the American Heart Association. Circulation 123:816-832
26. Guinhouya BC, Samouda H, Zitouni D, Vilhelm C, Hubert H (2011) Evidence of the influence of physical activity on the metabolic syndrome and/or on insulin resistance in pediatric populations: a systematic review. Int J Pediatr Obes 6:361-388
27. Härter MC (2000) Psychische Störungen bei körperlichen Erkrankungen. Psychother Psychosom Med Psychol 50:274-286
28. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA (2007) Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7:220
29. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J (2010) Body mass index, waist circumference and waist: hip ratio as predictors of cardiovascular risk - a review of the literature. Eur J Clin Nutr 64:16-22
30. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132-140
31. Kimball AB, Wu EQ, Guerin A, Yu AP, Tsaneva M, Gupta SR, Bao Y, Mulani PM (2012) Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol in press
32. Kimball AB, Wu Y (2009) Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Int J Dermatol 48:1147-1156
33. Lloyd LJ, Langley-Evans SC, McMullen S (2012) Childhood obesity and risk of the adult metabolic syndrome: a systematic review. Int J Obes (Lond) 36:1-11
34. Mlinar B, Marc J (2011) Review: new insights into adipose tissue dysfunction in insulin resistance. Clin Chem Lab Med 49:1925-1935
35. Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Muller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B (2012) S3 - Guidelines on the treatment of psoriasis vulgaris. Update. J Dtsch Dermatol Ges 10(Suppl 2):S1-S95
36. Owen DR, Lindsay AC, Choudhury RP, Fayad ZA (2011) Imaging of atherosclerosis. Annu Rev Med 62:25-40
37. Padayachee L, Rodseth RN, Biccard BM (2009) A meta-analysis of the utility of C-reactive protein in predicting early, intermediate-term and long term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 64:416-424
38. Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Honigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne JP, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B (2009) European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 23(Suppl 2):1-70
39. Pereira IA, Borba EF (2008) The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis. Swiss Med Wkly 138:534-539
40. Pietrzak A, Michalak-Stoma A, Chodorowska G, Szepietowski JC (2010) Lipid disturbances in psoriasis: an update. Mediators Inflamm pii: 535612
41. Prey S, Paul C, Bronsard V, Puzenat E, Gourraud PA, Aractingi S, Aubin F, Bagot M, Cribier B, Joly P, Jullien D, Le Maitre M, Richard-Lallemand MA, Ortonne JP (2010) Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 24(Suppl 2):23-30
42. Qureshi AA, Dominguez PL, Choi HK, Han J, Curhan G (2010) Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol 146:1364-1369
43. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hobbs R, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Funck-Brentano C, Poldermans D, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL (2011) ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology and the European Atherosclerosis Society. Eur Heart J 32:1769-1818
44. Reuter K, Harter M (2011) Screening und Diagnostik komorbider psychischer Storungen bei korperlichen Erkrankungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 54:22-28
45. Schäfer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M (2011) Epidemiologie der Psoriasis in Deutschland-Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung. Gesundheitswesen 73:308-313
46. Schmieder RE (2010) End organ damage in hypertension. Dtsch Ärztebl Int 107:866-873
47. Shimada K (2009) Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis. Circ J 73:994-1001
48. Szepietowski JC, Bielicka E, Wasik F, Kopec W, Szepietowski T (2000) Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol 14:513-514
49. Whitworth JA (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983-1992
50. Whooley MA, Avins AL, Miranda J, Browner WS (1997) Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 12:439-445
51. Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL (2011) C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med 123:114-119
52. Boehncke S, Salgo R, Garbaraviciene J, Beschmann H, Ackermann H, Boehncke WH, Ochsendorf FR (2011) Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: results of a prospective longitudinal pilot study. Arch Dermatol Res 303:417-424
53. Cheng J, Kuai D, Zhang L, Yang X, Qiu B (2012) Psoriasis increased the risk of diabetes: a meta-analysis. Arch Dermatol Res 304:119-125
54. De Marco G, Cattaneo A, Battafarano N, Lubrano E, Carrera CG, Marchesoni A (2012) Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients. Arch Dermatol Res 304:719-726
55. Janowski K, Steuden S, Pietrzak A, Krasowska D, Kaczmarek L, Gradus I, Chodorowska G (2012) Social support and adaptation to the disease in men and women with psoriasis. Arch Dermatol Res 304:421-432
56. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Dauden E, Gisondi P, Iversen L, Kemeny L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N (2011) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303:1-10
57. Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Muller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B (2012) German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res 304:87-113
58. Romani J, Caixas A, Ceperuelo-Mallafre V, Carrascosa JM, Ribera M, Rigla M, Vendrell J, Luelmo J (2012) Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI. Arch Dermatol Res. doi: 10.1007/s00403-012-1306-5 [Epub ahead of print]
59. Thorslund K, Amatya B, Dufva AE, Nordlind K (2012) The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress. Arch Dermatol Res. doi: 10.1007/s00403-012-1303-8 [Epub ahead of print]
60. Velez NF, Wei-Passanese EX, Husni ME, Mody EA, Qureshi AA (2012) Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res 304:7-13